Earnings calls / CLEDUCATE · August 5, 2026

CL Educate Ltd Q1 FY27 Earnings Call Summary

Q1 FY27 revenue fell ~₹17.5 crore YoY, but EBITDA margin rose 218 bps to 16.6% on ₹18 crore cost cuts, with test prep down 15% to ₹45 crore and Martech up 3.8% with 32% EBITDA growth. The real driver was cost discipline, not demand, as Dexit deferred ₹4.7 crore revenue and lost a ₹6 crore rollover, while PAT stayed negative. Management guides continued YoY EBITDA margin expansion each quarter, Dexit revenue normalization in Q2, and zero net debt within 36 months. Main risks: MBA test prep churn, NTA in-house technology moves, and unsustainably low tender bids.

Revenue
Margin
Demand
Guidance
Tone

Event Participants

Executives – 5

Arjun Wadhwa, Satya Narayanan R, Nikhil Mahajan, Gautam Puri, Yatrik Vin

Analysts – 4

Aditya Diora, Henil Bagadia, Manu Jindal, Rahul Bansali

Financials & KPIs

Metric Reported Commentary
Revenue (Overall) Decline of ~₹17.5 crores YoY Slight revenue decline driven by exam rollover (₹6 crore in Q1 FY26 that didn't repeat), ₹4.7 crore deferred revenue pending customer result declaration, and test prep market churn
EBITDA Margin 16.6% Up 218 bps YoY; driven by ₹18 crore cost rationalization (₹9.3 crore service delivery cost + ₹8.7 crore fixed overhead reduction)
EBITDA (Absolute) Marginally higher YoY, "significantly higher" QoQ Q1 is seasonally the weakest quarter for digital assessments and Martech; EBITDA improvement despite revenue decline shows cost discipline
PAT Still negative After-tax profitability negative due to interest and depreciation charges; Q1 is the leanest quarter for key segments
Finance Cost ₹10.6 crores Declined ~17% from ₹12.8 crores in Q1 FY26
Depreciation & Amortization ~₹14.3 crores (implied) Increased 28% from ₹11.2 crores due to capex additions in Q4FY26; depreciation ₹3.5 crores in Q1 FY27 vs ₹2.3 crores last year
Other Income ₹4.5 crores Up from ₹3 crores in Q1 FY26
Test Prep Revenue ₹45 crores Declined 15% YoY from ₹53 crores; EBITDA down 13% but margin expanded 60 bps
Test Prep EBITDA Margin +60 bps YoY Expansion supported by franchise revenue mix shift (higher contribution vs. central operations) and price increases, partially offset by volume decline
Digital Assessment (Dexit) Revenue Down 17% YoY Non-repeat of ₹6 crore exam rollover from FY26 Q4 and ₹4.7 crore pending revenue recognition expected to resolve in Q2
Digital Assessment EBITDA Down 4.3% YoY Resilient despite revenue decline; high operating leverage deferred
Martech Revenue +3.8% YoY (~₹7 crore growth) Q1 is seasonally leanest quarter as marketing budgets release from May-June; Q2/Q3 are heaviest
Martech EBITDA +32% YoY Margin expanded ~180 bps to ~25-30% range
New Contracts (Dexit) 9 contracts, TCV ₹34 crores ₹22 crores to be executed in FY27, balance in FY28; multi-year contracts
Acquisition Debt (Dexit) ₹174 crores Reduced from ₹210 crores initial acquisition financing; repayment on schedule
Technology Contribution (Martech) ~10% of revenue (FY26) Expected to reach 13-15% of current year revenue, driving margin expansion
Other Income ₹4.5 crores vs ₹3 crores YoY Supporting overall profitability

Geographic & Segment Commentary

  • Test Prep (EdTech): Revenue declined 15% YoY to ₹45 crores, with EBITDA down 13% but margin expansion of 60 bps. Structural market readjustment continues with AI-led acceleration in free online learning resources. Franchise revenue now contributes a higher share versus central operations, aiding realization, but volume decline from market churn wasn't fully offset by price increases. MBA – the largest vertical – is undergoing significant market churn, though churn industry-wide is stabilizing with green shoots in certain product segments. BBA/IPM is a growth segment, buoyed by more institutes offering 5-year MBA and 3-4 year programs.

  • Digital Assessment (Dexit): Revenue down 17% YoY; EBITDA down 4.3%. The ₹4.7 crore deferred revenue is expected to be recognized in Q2 once customers declare results. The business won 9 new contracts worth ₹34 crore TCV (₹22 crore in current year). 60-65% of business is government (tender-based), allowing steady, predictable revenue; balance is private. Demand is expected to accelerate given the post-NEET scrutiny on exam integrity. BYOD (Bring Your Own Device) rollout is key enabler for anywhere-anytime exams.

  • Martech (Enterprise): Revenue up ~3.8% YoY with EBITDA up 32%, margin expansion of ~180 bps. Q1 is seasonally the lightest quarter as marketing budgets typically release from May-June; large corporate events cluster July to mid-December before Christmas closure. New blue-chip customers secured in Singapore and Indonesia. Q2 and Q3 expected to be heaviest delivery seasons with marquee brands lined up in India, Singapore, and US.

  • Easy Apply (Platform Monetization): Continuing to scale well with 5x application growth in the prior admission cycle; new admission cycle just activated with "extremely positive traction" in first 15 days of August. Now onboards most well-known management institutes and exams except IIMs. Q1 is inherently slow as institutions close prior-year admission cycles.

Company-Specific & Strategic Commentary

  • AI & Technology Adoption: ~74% of coding now AI-enabled; AI has collapsed innovation lead times from 6-12 months to 4-6 weeks, enabling concurrent projects without incremental technology people cost. Cost rationalization contributed significantly to EBITDA without sacrificing growth ideas for next 3-6 quarters.

  • Exam Rationalization & Assessment Demand: Management expects acceleration toward digital assessments (CBT and potentially computer adaptive testing later), rationalization of multiplicity of exams (similar to historical consolidation of engineering and medical entrance exams), and growth in total assessment takers given higher education enrollments projected to grow ~60% over next nine years. This is expected to create both new opportunities and consolidation on both assessment and test prep sides over 12-24 months.

  • Capital Reduction & RPS Redemption: NCLT approval received in second week of July; ROC approvals received; redemption of preference shares (from Dexit acquisition) expected to be completed within August. Will optimize and resize the balance sheet and remove legacy loading.

  • Versa AI Agentic Tool: AI-driven account-based marketing tool; pilots successfully completed with Salesforce and Dell, and now scaled to recurring campaigns; Infosys pilot expanded to multi-division implementation across India, with APAC and US expansions underway (90-150 day implementation cycles, expected done by end Q2/early Q3). Additional pilots underway with Deloitte, PwC, Elastic and AWS divisions.

  • Debt Reduction Strategy: Targeting zero net debt within 36 months; ₹210 crore acquisition loan for Dexit reduced to ₹174 crores. Strategic discussions underway with large global and Indian players (potential outcomes in next two quarters). Management balancing growth, return on capital employed, and zero-debt status.

Guidance & Outlook

Metric Guidance / Outlook Commentary
EBITDA Margin Continued YoY expansion on quarter-to-quarter basis through FY27 Mix shifts between core and gateway businesses may cause some margin movement, but management committed to margin expansion vs. prior year each quarter
Digital Assessment Revenue (Q2 FY27) Expected in line with plan and prior year levels Resolution of ₹4.7 crore deferred revenue plus already-signed contracts expected to normalize Q2 performance
Martech Technology Contribution 13-15% of revenue in FY27 (up from ~10% in FY26) Driven by Wasmos and Versa adoption, supports margin expansion
Versa Revenue Growth 45-50% growth in current fiscal year Based on successful pilots scaling to larger deployments and expansion into APAC/US
Debt Zero net debt in 36 months Current repayment on schedule; accelerated repayment possible if excess cash isn't needed for business growth (Martech and Dexit expansions require capital)
Annualized Cost Rationalization Full year benefit reflecting through previous 12 months in Q2/Q3 before tapering Six-month phased cost optimization kickstarted in Q3 FY26 continues to benefit through FY27
RPS Redemption Completion expected within August 2026 NCLT and ROC approvals received; wind-up underway

Risks & Constraints

Risk Context
NTA In-house Technology Development With public scrutiny on exam conduct, NTA (or government) could develop in-house assessment software/hardware. Management views this as a positive, arguing that few players (including Dexit) meet the threshold of robust technology, AI-enabled proctoring, and live centralized monitoring. Tender-based competition remains intense, with some bidders quoting unsustainably low prices (STL1/L1 issues)
Test Prep Structural Headwinds MBA – the largest vertical – is undergoing significant market churn. AI-enabled free online learning resources and Physics Walla's lower-end pricing pressure continue to compress demand at the middle-to-upper segment where CL Educate primarily operates. Though industry churn is stabilizing, volume decline hasn't been fully compensated by price increases; BBA/IPM and 3-4 year programs offer partial offsets
Exam Rationalization Impact Consolidation of exams (into 3-4 common entrance tests at UG/PG level) may eliminate certain existing exam contracts and reshape the assessment market, though management expects overall assessment volumes to increase as enrollments grow ~60% over nine years. Specific impact on existing contracts will only be visible over next few quarters
Revenue Timing & Seasonality Concentration Q1 is consistently the leanest quarter for both Dex and Martech; delays in customer result declarations (₹4.7 crore) and non-repeat of rollover business (₹6 crore) highlight sensitivity to client timelines. Concentration of Martech revenue in July-December window adds seasonality risk
Governance/Regulatory Scrutiny NEET-led controversies have put all exam-conducting agencies under heightened regulatory scrutiny. Management cites this as an opportunity given Dexit's technology stack, but acknowledges the assessment business is "not easy" and "risky" — any lapse could have outsized reputational impact in an environment of elevated public sensitivity

Q&A Highlights

Exam Rationalization & Growth Outlook

  • Question: How is exam rationalization likely to impact the business, and what's the growth outlook for Dexit in near/medium term? (Rahul Bansali)
  • Answer: India has far too many UG/PG-level exams; consolidation toward 3-4 common entrance tests (like SAT at UG level, GMAT/GRE at PG level) is likely, as already seen in engineering and medical. Some existing exams may morph into new ones; new opportunities will emerge. Direction is toward aptitude/cognitive skills that are domain-agnostic and geography-agnostic. Timeline of 12-24 months is too early to predict specifics. Higher education enrollments need to grow ~60% over next nine years, expanding the addressable market. (Satya Narayanan R)

NTA In-house Software Risk

  • Question: With scrutiny on exam conduct, how do we counter the risk that NTA might develop in-house software/hardware to mitigate malpractice? (Rahul Bansali)
  • Answer: Management views this as a good opportunity — if harder scrutiny is applied to the assessment side, not more than a couple of companies (including Dexit) will pass the threshold for robust technology, AI-enabled proctoring, and live real-time remote monitoring from control rooms. "It's a good opportunity if you're a good brand, a trustworthy player who can not only do quality service but also can scale up." (Satya Narayanan R)
  • Supplement: Dexit's technology stack is considered futuristic with significant AI in remote proctoring. 60-70% of FY26-27 technology projects are complete, covering examination engine, cyber/IT security, network layer, and expanding nodes across the country. BYOD rollout will democratize education globally — anywhere, anytime exams. Divisions operate at 25-30% EBITDA margins even in headwind quarters. (Yatrik Vin)

EBIT vs EBITDA Difference

  • Question: Explain the difference between segment results (EBIT) and EBITDA in the presentation, specifically for Dexit. (Aditya Diora)
  • Answer: Other income was ₹4.5 crores this year vs. ₹3 crores last year; depreciation was ~₹3.5 crores versus ₹2.3 crores last year — these differences explain the gap between EBITDA and reported segment EBIT. (Arjun Wadhwa)

BBA/IPM Business and Physics Walla Impact

  • Question: How is the BBA and IPM business doing this year, and what's the impact of Physics Walla's AI-led content creation on test prep? (Henil Bagadia)
  • Answer: BBA/IPM is the growth segment; more institutes are offering five-year MBA programs and three/four-year alternatives, which will drive further growth. AI for content generation has been in use for 1.5-2 years — it's not new. Competitive positioning is differentiated: Physics Walla targets the lower end while CL Educate focuses on middle-to-upper market segments; content quality and market acceptance are the key differentiators. (Gautam Puri)

AI in Proctoring & Dexit Suite

  • Question: How is Dexit using AI in proctoring development, especially given the current NTA/NEET environment? (Henil Bagadia)
  • Answer: Dexit has three layers of monitoring: on-ground physical proctoring (frisking, physical security at centers), centralized remote monitoring from Mumbai HQ (zoom-in to each center and each desk, can kill a student's computer if misconduct persists), and an added center-level layer. The AI layer captures iris, facial movement, and even the smallest sound bite — warnings flash on the student's desktop and the system can terminate the session. "Very few institutions in this country or the world have this kind of solution available for their digital assessment piece." (Yatrik Vin)

Debt Reduction Plans & Strategic Discussions

  • Question: What are the debt reduction plans over the next couple of years? (from investor via chat)
  • Answer: The ₹210 crore acquisition loan is down to ₹174 crores. Target is zero net debt in 36 months — repayments on schedule. Strategic discussions are ongoing with large global and Indian players; any developments would be shared when appropriate (potentially emerging over next two quarters). Management balances growth investments (Martech, Dexit market expansion), return on capital employed, and zero-debt status. (Nikhil Mahajan, with augmentation from Yatrik Vin)

Pricing Strategy for Assessments

  • Question: How does the pricing strategy work — per seat, per center — and how price-sensitive is the assessment business? (Manu Jindal)
  • Answer: Charging is on a per-candidate (per seat) basis. 60-65% of business is government (central and state), which is tender-based (techno-commercial evaluation). Dexit consistently scores on technology due to its track record; occasionally loses on the L1 (lowest bid) parameter when competitors quote unsustainably low prices. The 30-35% non-tender business is steady and predictable. Revenue generally recognized post-examination or post-result declaration; no advance payments are received. (Yatrik Vin)

Versa in Singapore and North America

  • Question: How is Versa progressing in different markets, especially Singapore and North America? (from investor via chat)
  • Answer: Versa launched ~2-2.5 quarters back. Salesforce and Dell pilots scaled up to recurring activations/campaigns; Infosys pilot expanded from India to multi-division implementations, with APAC and US panelment underway (90-150 day cycles; expected completion by end Q2/early Q3). Additional pilots with Deloitte, PwC, Elastic, and AWS divisions are underway before large-scale adoption. Targeting 45-50% overall revenue growth in the current year. (Nikhil Mahajan)

Key Takeaway

CL Educate reported a mixed Q1 FY27: revenue declined ~₹17.5 crores YoY (impacted by non-repeat of ₹6 crore Dexit exam rollover, ₹4.7 crore deferred assessment revenue, and ongoing test prep churn), but disciplined cost rationalization (₹18 crores: ₹9.3 crore service delivery + ₹8.7 crore overhead cuts) drove EBITDA margin expansion of 218 bps to 16.6% and positive EBITDA across all divisions. Test prep revenue was down 15% to ₹45 crores with margin up 60 bps; Dexit won 9 new contracts worth ₹34 crore TCV; Martech grew ~3.8% revenue with 32% EBITDA growth, aided by Versa's scaling with Salesforce, Dell, Infosys, and new customers in Singapore/Indonesia. Management sees the post-NEET policy environment as an opportunity — exam rationalization toward digital, consolidated CBT assessments and heightened integrity standards could disproportionately benefit Dexit given its AI-enabled multi-layered proctoring stack (with ~74% of coding now AI-enabled). RPS redemption completed (NCLT and ROC approvals in hand) will resize the balance sheet, with zero net debt targeted in 36 months (₹174 crores outstanding). Q2/Q3 should normalize revenue as deferred recognitions materialize and peak Martech/Dexit delivery seasons begin; key watch points remain MBA test prep recovery, NTA/government in-house technology moves, and the pace of global Versa expansion (targeting 45-50% growth this fiscal).

What you get with InvestorStack

Institutional-grade research, built for individual investors.

  • Research Reports for every listed Indian company
  • Detailed valuation models
  • Growth triggers, Risks, KPIs, Read between the lines
  • Scans, One pagers, Industry research reports
Try for free